Inventia Life Science is advancing 3D bioprinting technology to revolutionise biomedical research and drug discovery. The company's strong foundation of fundamental research has led to the development of a proprietary platform encompassing drop-on-demand bioprinting technology, an expanding library of printable matrices and custom protocols for specific applications. The RASTRUM platform is now available to enable efficient and powerful bioprinting of 3D cell-based assays for biomedical research.